Vascular Simulations, Inc.

Vascular Simulations, Inc. develops advanced simulation technology that enhances training and operational efficiency within the healthcare sector, focusing specifically on vascular procedures to improve patient outcomes. Founded in 2011 in the United States, Vascular Simulations, Inc. specializes in immersive training solutions for medical professionals in the vascular field.

The company was acquired by Mentice AB, a portfolio company of Bure, in October 2020 for approximately USD 5. 6 mn. The company is led by CEO Henry Woo, who has a history in simulating technologies for healthcare training. Vascular Simulations, Inc.

provides an innovative suite of products aimed at addressing challenges in vascular training. Their offerings include advanced simulation technology that bolsters efficiency and effectiveness for medical professionals. The products are strategically targeted towards healthcare providers, enhancing operational capabilities and decision-making processes. End users, including clinicians and surgical teams, benefit from these tools to elevate training standards in hospitals and educational institutions.

The company operates across key geographical markets, including North America, Europe, and Asia-Pacific. Vascular Simulations, Inc. generates revenue through a combination of direct sales and subscription-based agreements. Their client engagements primarily occur through B2B relationships, enabling businesses to secure access to their products via tailored contracts.

Clients often select annual subscription models that include ongoing services such as software updates and support. Additionally, the company collaborates with healthcare institutions to distribute its solutions, ensuring a stable revenue stream that sustains ongoing development and market outreach. Looking ahead, Vascular Simulations, Inc. is poised to launch new product innovations designed to further enhance training in vascular procedures.

The anticipated launch will take place in the upcoming fiscal year. The company aims to expand its market reach into new regions, specifically targeting Southeast Asia and South America by 2023. The recent acquisition and the funding of USD 5. 6 mn will be utilized to support these growth initiatives, focusing on product development and international market penetration.